Fig. 5From: Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancerKaplan–Meier survival curves for the 8 Gy, 10 Gy and 5 Gy in 2 fractions boost cohorts after radiation therapyBack to article page